Metoclopramide NDC 63629-2144

NDC codes

FDA NDC Directory

Product NDC (as listed)63629-2144Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63629-2144Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63629-2144-1	63629214401	473 mL in 1 BOTTLE (63629-2144-1)Marketed from Feb 8, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Metoclopramide
Generic name (nonproprietary): metoclopramide
Active ingredients: Metoclopramide hydrochloride — 5 mg/5mL
Dosage form: Solution
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 071402
Marketing start: May 18, 2015
Listing expires: Dec 31, 2026
Other FDA classes: Dopamine D2 Antagonists (Mechanism)
Identifiers: Product ID 63629-2144_bdfea23c-d79f-47f3-8d59-57ee336fd35dSPL ID bdfea23c-d79f-47f3-8d59-57ee336fd35dSPL set ID 14114420-fee0-4850-b99e-cdb5f421cd33RxCUI 104884UNII W1792A2RVD
Pharmacologic class: Dopamine-2 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463629214401 followed by a unit qualifier and the quantity

Package 63629-2144-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 18, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE The use of Metoclopramide Oral Solution is recommended for adults only. Therapy should not exceed 12 weeks in duration. Symptomatic Gastroesophageal Reflux Metoclopramide Oral Solution is indicated as short-term (4 to 12 weeks) therapy for adults with symptomatic, documented gastroesophageal reflux who fail to respond to conventional therapy. The principal effect of metoclopramide is on symptoms of post-prandial and daytime heartburn with less observed effect on nocturnal symptoms. If symptoms are confined to particular situations, such as following the evening meal, use of metoclopramide as single doses prior to the provocative situation should be considered, rather th…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 071402

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 071402
Product	Strength	Form · route	Labeler	Product NDC
Metoclopramide	Metoclopramide hydrochloride 5 mg/5mL	SolutionOral	ATLANTIC BIOLOGICALS CORP.	17856-1190
Metoclopramide	Metoclopramide hydrochloride 5 mg/5mL	SolutionOral	Bryant Ranch Prepack	72162-1750
Metoclopramide	Metoclopramide hydrochloride 5 mg/5mL	SolutionOral	American Health Packaging	60687-837
Metoclopramide	Metoclopramide hydrochloride 5 mg/5mL	SolutionOral	ANI Pharmaceuticals, Inc.	62559-190
Metoclopramide	Metoclopramide hydrochloride 5 mg/5mL	SolutionOral	Bryant Ranch Prepack	71335-2732
Metoclopramide	Metoclopramide hydrochloride 5 mg/5mL	SolutionOral	Bryant Ranch Prepack	71335-2997
Metoclopramide	Metoclopramide hydrochloride 5 mg/5mL	SolutionOral	Bryant Ranch Prepack	63629-1961